Cargando…
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
Idiopathic thrombocytopenic purpura (ITP) is a disease in which the immune system attacks platelets and decreases their number, which increases the patient's risk of bleeding. ITP is diagnosed by exclusion and usually manifests as acute disease. It is self-limiting in pediatric patients, while...
Autores principales: | Ahmed, Mohanad, Yassin, Mohamed A, Abdelmahmuod, Elabbass |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544552/ https://www.ncbi.nlm.nih.gov/pubmed/33052268 http://dx.doi.org/10.7759/cureus.10305 |
Ejemplares similares
-
Eltrombopag Dose Adjustment During Infection-Induced Thrombocytosis in a Patient With Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2021) -
Treatment-Free Remission in Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Iron Deficiency Anemia-Induced Neutropenia in Adult Female
por: Abdelmahmuod, Elabbass, et al.
Publicado: (2020) -
Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
por: Ahmed, Mohanad A., et al.
Publicado: (2020) -
Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
por: Abdelmahmuod, Elabbass A., et al.
Publicado: (2021)